Literature DB >> 16824629

Characterization of adenosine transport in H9c2 cardiomyoblasts.

George P H Leung1, Chung-Ming Tse, Ricky Y K Man.   

Abstract

Adenosine plays a significant role in various physiological processes including cardioprotection. Nucleoside transporters modulate adenosine levels in the vicinity of adenosine receptors, which in turn modulate adenosine functional efficacy. In the current study, adenosine transport in the rat heart myoblast cell line H9c2 was characterized. Kinetic analysis of adenosine transport in H9c2 cells revealed a Km of 8.9+/-0.001 microM and a Vmax of 32.1+/-0.65 pmol/mg protein/min. Adenosine transport in H9c2 cells was Na+-independent. About 6% of the total adenosine uptake was sensitive to nitrobenzylmercaptopurine riboside (NBMPR); however, 94% was insensitive, suggesting that adenosine uptake by H9c2 cells was predominantly mediated by the equilibrative nucleoside transporter (ENT)-2 and only mildly by ENT-1. Results of RT-PCR demonstrated the presence of mRNA for ENT-1, ENT-2 and ENT-3. Upon culture in a cell differentiation medium containing fetal bovine serum (1%) and retinoic acid (10 nM), both the activity and mRNA expression of ENT-1 increased 3-fold, however, ENT-2 was unaffected. Pharmacological studies revealed that ENT-1 activity was stimulated by PKA and PKC-delta/epsilon, however, ENT-2 activity was unaffected. Taken together, the exceptionally high expression level of ENT-2 in H9c2 cells raises questions regarding the use of H9c2 cells as a model for physiological adenosine activity in the heart. Furthermore, this study may form the basis for further investigation into the effect of cell differentiation and protein kinases on the regulation of nucleoside transporters.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824629     DOI: 10.1016/j.ijcard.2006.03.044

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling.

Authors:  Buel D Rodgers; Jillian P Interlichia; Dilip K Garikipati; Ranganath Mamidi; Murali Chandra; O Lynne Nelson; Charles E Murry; Luis F Santana
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

2.  Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection.

Authors:  Jennifer B Rose; Zlatina Naydenova; Andrew Bang; Megumi Eguchi; Gary Sweeney; Doo-Sup Choi; James R Hammond; Imogen R Coe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-24       Impact factor: 4.733

Review 3.  Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury?

Authors:  Cui Yang; George P H Leung
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.